Bioresponsive and immunotherapeutic nanomaterials to remodel tumor microenvironment for enhanced immune checkpoint blockade

Immune checkpoint blockade (ICB) therapy is a revolutionary approach to treat cancers, but still have limited clinical applications. Accumulating evidence pinpoints the immunosuppressive characteristics of the tumor microenvironment (TME) as one major obstacle. The TME, characterized by acidity, hyp...

Descripción completa

Detalles Bibliográficos
Autores principales: Fang, Tianxu, Cao, Xiaona, Wang, Li, Chen, Mo, Deng, Yueyang, Chen, Guojun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: KeAi Publishing 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10660011/
https://www.ncbi.nlm.nih.gov/pubmed/38026439
http://dx.doi.org/10.1016/j.bioactmat.2023.10.023

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10660011/
https://www.ncbi.nlm.nih.gov/pubmed/38026439
http://dx.doi.org/10.1016/j.bioactmat.2023.10.023

Ejemplares similares